Boc-Cys(Acm)-OHCAS# 19746-37-3 |
Quality Control & MSDS
Number of papers citing our products
Chemical structure
3D structure
| Cas No. | 19746-37-3 | SDF | Download SDF |
| PubChem ID | 88223 | Appearance | Powder |
| Formula | C11H20N2O5S | M.Wt | 292.4 |
| Type of Compound | N/A | Storage | Desiccate at -20°C |
| Solubility | Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. | ||
| Chemical Name | (2R)-3-(acetamidomethylsulfanyl)-2-[(2-methylpropan-2-yl)oxycarbonylamino]propanoic acid | ||
| SMILES | CC(=O)NCSCC(C(=O)O)NC(=O)OC(C)(C)C | ||
| Standard InChIKey | HLCTYBOTPCIHTG-QMMMGPOBSA-N | ||
| Standard InChI | InChI=1S/C11H20N2O5S/c1-7(14)12-6-19-5-8(9(15)16)13-10(17)18-11(2,3)4/h8H,5-6H2,1-4H3,(H,12,14)(H,13,17)(H,15,16)/t8-/m0/s1 | ||
| General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
| About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
| Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. | ||
Boc-Cys(Acm)-OH Dilution Calculator
Boc-Cys(Acm)-OH Molarity Calculator
| 1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
| 1 mM | 3.42 mL | 17.0999 mL | 34.1997 mL | 68.3995 mL | 85.4993 mL |
| 5 mM | 0.684 mL | 3.42 mL | 6.8399 mL | 13.6799 mL | 17.0999 mL |
| 10 mM | 0.342 mL | 1.71 mL | 3.42 mL | 6.8399 mL | 8.5499 mL |
| 50 mM | 0.0684 mL | 0.342 mL | 0.684 mL | 1.368 mL | 1.71 mL |
| 100 mM | 0.0342 mL | 0.171 mL | 0.342 mL | 0.684 mL | 0.855 mL |
| * Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. | |||||
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
Boc-Cys(Acm)-OH
- Latisxanthone C
Catalog No.:BCN7346
CAS No.:197447-32-8
- Isocudraniaxanthone A
Catalog No.:BCN7426
CAS No.:197447-26-0
- (2RS)-Lotaustralin
Catalog No.:BCN7848
CAS No.:1973415-50-7
- 11-Dehydroxygrevilloside B
Catalog No.:BCN4867
CAS No.:197307-49-6
- Glycyrrhiza flavonol A
Catalog No.:BCN7995
CAS No.:197304-01-1
- Methiothepin maleate
Catalog No.:BCC6706
CAS No.:19728-88-2
- Z-Thr-OH
Catalog No.:BCC2751
CAS No.:19728-63-3
- Gap 26
Catalog No.:BCC1032
CAS No.:197250-15-0
- NTR 368
Catalog No.:BCC5872
CAS No.:197230-90-3
- Delta-9-Tetrahydrocannabinol
Catalog No.:BCN8074
CAS No.:1972-08-3
- Pseudopalmatine
Catalog No.:BCN4866
CAS No.:19716-66-6
- 8-Oxycoptisine
Catalog No.:BCN3136
CAS No.:19716-61-1
- 2-Methyl-4-nitrobenzoic acid
Catalog No.:BCC8580
CAS No.:1975-51-5
- TRAM 39
Catalog No.:BCC8038
CAS No.:197525-99-8
- Calystegine A7
Catalog No.:BCN1885
CAS No.:197565-90-5
- Calystegine B5
Catalog No.:BCN1883
CAS No.:197565-91-6
- Fmoc-β-HomoTrp(Boc)-OH
Catalog No.:BCC2625
CAS No.:197632-75-0
- Fmoc-D-β-HomoTrp(Boc)-OH
Catalog No.:BCC2624
CAS No.:197632-75-1
- Fmoc-N-Me-Ser(tBu)-OH
Catalog No.:BCC3353
CAS No.:197632-77-2
- Tigecycline hydrochloride
Catalog No.:BCC4228
CAS No.:197654-04-9
- Mesna
Catalog No.:BCC3811
CAS No.:19767-45-4
- Loxapine
Catalog No.:BCC4026
CAS No.:1977-10-2
- Ajugatakasins A
Catalog No.:BCN3661
CAS No.:197723-20-9
- Peimisine
Catalog No.:BCN4992
CAS No.:19773-24-1
[Synthesis of a partially purified fragment of salmon calcitonin 1-16 using a phenylhydrazide protective group].[Pubmed:8498959]
Bioorg Khim. 1993 Feb;19(2):182-9.
The partially protected fragment Boc-Cys(Acm)-Ser(Bu(t))-Asn-Leu-Ser(Bu(t))-Thr (Bu(t))-Cys(Acm)-Val-Leu-Gly-Lys(Boc)-Leu-Ser(Bu(t))-Gln-Glu(OBu(t ))- Leu-OH of salmon calcitonin was synthesized by the segment condensation in solution. Segments were synthesized by the DCC/HOBt method in solution with phenylhydrazide as a semipermanent protecting group for the carboxyl function of the C-terminal residue. The phenylhydrazide group was removed by oxidation with air oxygen catalyzed by copper pyridine complexes under mild conditions. The segments were then condensed by the DCC/HOBt method according to the scheme (6 + 3) + (3 + 4). The proposed scheme makes it possible to product the partially protected fragment 1-16 of salmon calcitonin on the gram scale.
Protection of asparagine and glutamine during N alpha-Bpoc-based solid-phase peptide synthesis.[Pubmed:8740971]
Int J Pept Protein Res. 1996 Mar;47(3):209-13.
In this paper we describe the synthesis and properties of Bpoc-Asn(Trt)-OH, Bpoc-Asn(Trt)-OPfp, Bpoc-Gln(Trt)-OH and Bpoc-Gln(Trt)-OPfp. These derivatives are highly soluble in CH2Cl2 and can be coupled efficiently in solid-phase peptide synthesis. The peptides, acetyl-Ala-Phe-Asn(Trt)-Gly-Leu-Ala-O-Dbf-SH and Boc-Cys(Acm)-Ala-Phe-Gln(Trt)-Gly-Leu-Ala-O-Dbf-SH (where O-Dbf-SH is the peptide ester of 4-mercapto-6-hydroxydibenzofuran) were synthesized by stepwise solid-phase peptide synthesis using N alpha-Bpoc amino acids. We have observed that less than 0.1% of the trityl group is removed from the carboxamide of Gln and Asn during a standard 15 min N alpha-Bpoc deprotection in 0.5% TFA in CH2Cl2.
